With $190K in ARRA Funding, 23andMe to Validate Web-based Platform to Spur PGx Collaborations

The company aims to show that its web-based, customer-reported data-gathering model yields results comparable to traditional research methods — both in terms of the accuracy of phenotypic data reported by customers, as well as the overall ability of the approach to replicate known associations between genes and drug response.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.